EVP& CBO, Ipsen

Corporate SVP, Global Head of BD&L, Boehringer Ingelheim

VP,Head of S&E & Transactions, GSK

Executive Director, BD&L, S&E, Merck

VP, Venture Science, Eli Lilly

VP, Venture Science, Eli Lilly

Vice President, Venture Capital, Eli Lilly

Global Chief DE&I Officer, Regeneron

VP, Head of BD, Alnylam Pharmaceuticals

Coporate Development, Gingko Bioworks

VP, Head US Commercial, Kite, A Gilead Company

Director, Business Development, Oncology, Astellas Pharma

Sr. Director Global Partnering, Neurosciences & Rare Diseases, Ipsen

Executive Director, Head of BD&L USA, Boehringer Ingelheim

Managing Director, Boehringer Ingelheim Venture Fund USA

VP Head of Collaborate to Cure USA, Bayer

SVP, M&A, BridgeBio

Sr. Associate Director, Strategic Partnering BD&L, Boehringer Ingelheim 

EVP & Head of Corporate Development, Biogen 

SVP, BD and M&A, BeiGene USA

Global Head, Partnering & BD, Sanofi

SVP Business Development, BMS

Head of Bio Innovation Hub, Novo Nordisk

Head of Corporate Development, Tillotts Pharma

Senior Director, S&E Oncology, GSK

Global head Oncology BD, Servier Monde 

SVP, Head of Business Development & Corporate Strategy, Moderna

Biotech Executive, Multiple Biotechs

CEO, LifeMine Therapeutics

CEO, Cerevance

CEO, Abliva

Chief Corporate Affairs Officer, Ovid Therapeutics

VP Corporate Development, Cerevance

President & Founder, OUTbio

CEO, Shorla Oncology

CEO, Coastar Therapeutics

CEO, Orange Grove Bio

Supervisor, Invention Development Unit, National Cancer Institute–NIH

Chief Business Development Officer & Chief Compliance and Legal Officer, Strata Oncology

Chairman, National Foundation

CEO Rejuvenate Bio

CEO, Hemab

CEO, Xontogeny 

VP Commercial Strategy and Operations, Aldeyra Therapeutics

Founder, CEO, & Chief Possibilities Officer, JBK Associates International

SVP, Market Access, Gamida Cell  

CEO, FibroFind

CFO, ORUM Therapeutics

Senior Business Editor, Genetic Engineering & Biotechnology News

COO, FibroFind

Healthcare Business Writer, The Boston Globe

Chief Commercial Officer, Roivant Life Sciences

Head of Strategy & partnerships, RenovoRx

CEO, siRNAgen

Health Reporter, USA Today

Managing Director, Perceptive Advisors

CEO-Partner, Flagship Pioneering

Partner, Pfizer Ventures & VP, Partnering Innovations, Pfizer

Managing Director, M Ventures

VP Venture Investment, J&J Innovation

Managing Director, Sanofi Ventures

Managing Partner, Forbion

General Partner, Canaan Partners

CBO, RTW Investments

Senior Partner, Flagship Pioneering

General Partner, Forbion

Partner, Head of Business Development, Apple Tree Partners

Managing Director, Life Sciences, Bain Capital

Principal, Sofinnova Investments

Director, Foresite Capital

Partner, 5AM Ventures

Principal, Atlas Venture Partners

Managing Partner, Graybella Capital

Managing Director, Vertex Ventures

Principal, venBio Partners

Partner, MPM BioImpact Capital

Venture Partner, Pathway Bioventures

Operating Partner, 3E Bioventures

Senior Managing Director, Blackstone Life Sciences

Managing Director, Back Bay Life Science Advisors

Partner, Foley Hoag

Member, Mintz

Partner, Morrison & Foerster

Partner, Fox Rothschild

Partner, RSM

Managing Director, Danforth Advisors

Chief Innovation Officer, Halloran Consulting

Partner, ZS

Strategic Advisor, NDA

Partner, Brown Rudnick

Partner, Brown Rudnick

Director, Healthcare M&A, Leerink Partners

EVP USA, Nucleus Networks

Chief Scientific & Medical Officer, NDA 

Director of DEI, Mass Bio

Executive Vice President Business Development, Nucleus Networks